What is the role of renal transplantation in a patient with nephrogenic systemic fibrosis?

Seminars in Dialysis

Volumn 24, Issue 4, 2011, Pages 373-374

  Panesar, Mandip ^a   Yacoub, Rabi ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; KIDNEY TRANSPLANTATION; NEPHROGENIC SYSTEMIC FIBROSIS; NOTE;

HUMANS; KIDNEY TRANSPLANTATION; NEPHROGENIC FIBROSING DERMOPATHY;

EID: 80051827181     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2011.00913.x     Document Type: Note

References (17)

1. Cowper SE, et al.: Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356:1000-1001, 2000
2. Grobner T: Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104-1108, 2006
3. Chung HJ, et al.: Nephrogenic fibrosing dermopathy: response to high-dose intravenous immunoglobulin. Br J Dermatol 150:596-597, 2004
4. Baron PW, et al.: Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis. Am J Dermatopathol 25:204-209, 2003
5. Lauchli S, et al.: Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis. Dermatology 208:278-280, 2004
6. Kay J, et al.: Imatinib mesylate treatment of nephrogenic systemic fibrosis. Arthritis Rheum 58:2543-2548, 2008
7. Kadiyala D, et al.: Nephrogenic systemic fibrosis associated with gadoversetamide exposure: treatment with sodium thiosulfate. Am J Kidney Dis 53:133-137, 2009
8. Richmond H, et al.: Nephrogenic systemic fibrosis: relationship to gadolinium and response to photopheresis. Arch Dermatol 143:1025-1030, 2007
9. Panesar M, et al.: Clinical improvement of nephrogenic systemic fibrosis after kidney transplantation. Clin Transplant 22:803-808, 2008
10. Leung N, et al.: The outcome of patients with nephrogenic systemic fibrosis after successful kidney transplantation. Am J Transplant 10:558-562, 2010
11. Cuffy MC, et al.: Renal transplantation for nephrogenic systemic fibrosis: a case report and review of the literature. Nephrol Dial Transplant 26(3):1099-1101, 2011
12. Thakral C, et al.: Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium-enhanced MRI scans: case report and implications. Contrast Media Mol Imaging 2:199-205, 2007
13. Abraham JL, et al.: Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis. Br J Dermatol 158:273-280, 2008
14. Leung N, et al.: Chelation of gadolinium with deferoxamine in a patient with nephrogenic systemic fibrosis. NDT Plus 2:309-311, 2009
15. Swaminathan S, et al.: Rapid improvement of nephrogenic systemic fibrosis with rapamycin therapy: possible role of phospho-70-ribosomal-S6 kinase. J Am Acad Dermatol 62:343-345, 2010
16. Kelly B, et al.: Nephrogenic systemic fibrosis is associated with transforming growth factor beta and Smad without evidence of renin-angiotensin system involvement. J Am Acad Dermatol 58:1025-1030, 2008
17. Auron A, et al.: Nephrogenic fibrosing dermopathy in children. Pediatr Nephrol 21:1307-1311, 2006